Home » Tenders » Americas » USA » Brand Name or Equivalent Human Biosensors Tender, USA - 100372068

Brand Name or Equivalent Human Biosensors Tender, USA - 100372068

HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Brand Name or Equivalent Human Biosensors. The project location is USA and the tender is closing on 29 Apr 2024. The tender notice number is SS-NIAID-24-2216215, while the TOT Ref Number is 100372068. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Brand Name or Equivalent Human Biosensors

Deadline : 29 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 100372068

Document Ref. No. : SS-NIAID-24-2216215

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

Introduction

This is a Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement.

Background, Purpose, Objectives

The Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC Virology Laboratory comprises the Virology, Humoral Immunology, and Structural Biology Sections and related Cores. The goal of the Virology Laboratory is to conduct research to understand better the cellular and molecular regulation of viral gene expression, viral entry into the host cell, optimization of immune responses to gene-based vaccination and correlates of immune protection, assessment of active and passive approaches for HIV-1 vaccine development, and to apply structural biology techniques toward rational vaccine design for emerging and re-emerging infectious diseases.

The Vaccine Research Center is developing vaccines for HIV-1 and other viruses. Currently, SBS/SBIS is working on developing vaccines for SARS-CoV-2. Production of wild-type and mutant viral proteins and anti-viral antibodies is critical in vaccine development. Making specific immunogens as probes is critical to isolate antibodies and develop therapeutic agents in the Covid19 treatment.

The Virology Laboratory is interested in procuring Streptavidin (SA) Biosensors from Sartorius Corporation for measuring protein-protein interactions, including Sera readout in ongoing immunization experiments on an Octet HTX system. This request is for a consumable to be used on this system.

Project Requirements

Successful offerors must have the knowledge, skill, ability, and resources to reliably provide a brand name or equal set of Streptavidin biosensors as follows. Note, the biosensors must be com...
Active Contract Opportunity Notice ID SS-NIAID-24-2216215 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 19, 2024 09:30 am EDT
Original Response Date: Apr 29, 2024 10:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 14, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Bethesda, MD 20892 USA